Even though a poor understanding of the exact molecular mechanisms of ACE2 variants on increased AF risk in patients with diabetes, accumulated evidence suggested that activation of RAAS triggers a series of events (e.g., left atrial remodeling, inflammation and thromboembolism) contributing to AF. Here, ACE2 is linked to Thromboembolism.